Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Raymakers

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Journal of Cellular and Molecular Medicine|March 4, 2010
Toll-like receptor triggering in cord blood mesenchymal stem cellsLieke C J van den Berk, Bastiaan J H Jansen, Kim G C Siebers-Vermeulen, et al.
Critical Care Medicine|August 30, 2019
Epidemiology and Outcome of Critically Ill Pediatric Cancer and Hematopoietic Stem Cell Transplant Patients Requiring Continuous Renal Replacement Therapy: A Retrospective Nationwide Cohort StudyPaulien A M A Raymakers-Janssen, Marc R Lilien, Dick Tibboel, et al.
Blood|April 7, 2006
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myelomaNiels W C J van de Donk, Nicolaus Kröger, Ute Hegenbart, et al.
Bone Marrow Transplantation|June 8, 2006
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myelomaN W C J van de Donk, N Kröger, U Hegenbart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2025
Nephrotoxicity and kidney outcomes in pediatric oncology patientsPaulien A M A Raymakers-Janssen, Nils Leitzinger, Gerrit van de Berg, et al.
Pediatric Nephrology (Berlin, Germany)|February 18, 2025
The incidence and outcome of acute kidney injury during pediatric kidney tumor treatment-a national cohort studyPaulien A M A Raymakers-Janssen, Gerrit van den Berg, Marc R Lilien, et al.
American Journal of Hematology|October 30, 2013
X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutationsDean R Campagna, Charlotte I de Bie, Klaus Schmitz-Abe, et al.
Blood|June 2, 2012
Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myelomaRichard W J Groen, Willy A Noort, Reinier A Raymakers, et al.
Cancers|February 25, 2022
Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line TherapyAnouk Steur, Paulien A M A Raymakers-Janssen, Martin C J Kneyber, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal of Cellular and Molecular Medicine|March 4, 2010
Toll-like receptor triggering in cord blood mesenchymal stem cellsLieke C J van den Berk, Bastiaan J H Jansen, Kim G C Siebers-Vermeulen, et al.
Critical Care Medicine|August 30, 2019
Epidemiology and Outcome of Critically Ill Pediatric Cancer and Hematopoietic Stem Cell Transplant Patients Requiring Continuous Renal Replacement Therapy: A Retrospective Nationwide Cohort StudyPaulien A M A Raymakers-Janssen, Marc R Lilien, Dick Tibboel, et al.
Blood|April 7, 2006
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myelomaNiels W C J van de Donk, Nicolaus Kröger, Ute Hegenbart, et al.
Bone Marrow Transplantation|June 8, 2006
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myelomaN W C J van de Donk, N Kröger, U Hegenbart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2025
Nephrotoxicity and kidney outcomes in pediatric oncology patientsPaulien A M A Raymakers-Janssen, Nils Leitzinger, Gerrit van de Berg, et al.
Pediatric Nephrology (Berlin, Germany)|February 18, 2025
The incidence and outcome of acute kidney injury during pediatric kidney tumor treatment-a national cohort studyPaulien A M A Raymakers-Janssen, Gerrit van den Berg, Marc R Lilien, et al.
American Journal of Hematology|October 30, 2013
X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutationsDean R Campagna, Charlotte I de Bie, Klaus Schmitz-Abe, et al.
Blood|June 2, 2012
Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myelomaRichard W J Groen, Willy A Noort, Reinier A Raymakers, et al.
Cancers|February 25, 2022
Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line TherapyAnouk Steur, Paulien A M A Raymakers-Janssen, Martin C J Kneyber, et al.
Pageof 9